- Home
- LEU vs IRMD Comparison
LEU vs IRMD Comparison
Compare LEU & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEU
- IRMD
- Stock Information
- Founded
- LEU 1998
- IRMD 1992
- Country
- LEU United States
- IRMD United States
- Employees
- LEU N/A
- IRMD N/A
- Industry
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- IRMD Medical/Dental Instruments
- Sector
- LEU Industrials
- IRMD Health Care
- Exchange
- LEU Nasdaq
- IRMD Nasdaq
- Market Cap
- LEU 3.1B
- IRMD 756.5M
- IPO Year
- LEU 1998
- IRMD 2014
- Fundamental
- Price
- LEU $201.89
- IRMD $58.02
- Analyst Decision
- LEU Strong Buy
- IRMD Strong Buy
- Analyst Count
- LEU 10
- IRMD 1
- Target Price
- LEU $171.67
- IRMD $72.00
- AVG Volume (30 Days)
- LEU 1.4M
- IRMD 67.2K
- Earning Date
- LEU 08-05-2025
- IRMD 07-31-2025
- Dividend Yield
- LEU N/A
- IRMD 1.14%
- EPS Growth
- LEU 40.85
- IRMD 10.72
- EPS
- LEU 6.39
- IRMD 1.55
- Revenue
- LEU $471,400,000.00
- IRMD $75,154,639.00
- Revenue This Year
- LEU $3.22
- IRMD $10.62
- Revenue Next Year
- LEU $9.91
- IRMD $9.69
- P/E Ratio
- LEU $32.28
- IRMD $38.37
- Revenue Growth
- LEU 58.72
- IRMD 11.04
- 52 Week Low
- LEU $33.51
- IRMD $42.34
- 52 Week High
- LEU $211.31
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- LEU 69.05
- IRMD 46.18
- Support Level
- LEU $167.26
- IRMD $58.44
- Resistance Level
- LEU $188.50
- IRMD $60.85
- Average True Range (ATR)
- LEU 16.92
- IRMD 1.62
- MACD
- LEU -0.79
- IRMD -0.40
- Stochastic Oscillator
- LEU 91.87
- IRMD 8.87
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.